← Ablatotech Vitals
Orthopedics EvidenceDigest

Current Evidence on the Use of Biodegradable Zinc-Based Implants for Fracture Fixation in Orthopedics

Orthopedics · EvidenceDigest

Reviewed by the Ablatotech Vitals editorial team
November 19, 2026 · Reviewer: Vitals Editorial Team
Educational use only. This digest is AI-curated commentary reviewed by clinicians. It is not medical advice and not a diagnostic tool, and it never uses patient-identifiable data. Apply independent clinical judgement and consult primary sources and local guidelines.

Biodegradable zinc-based implants represent a promising emerging option for fracture fixation in orthopedics, combining mechanical strength with gradual bioresorption. Early evidence suggests these implants may offer favorable biocompatibility and osteointegration compared to traditional metallic hardware, potentially reducing the need for secondary removal surgeries. However, clinical data remain limited and primarily preclinical or early-stage, warranting cautious interpretation. Orthopedic surgeons should consider zinc-based biodegradable implants as an investigational technology with potential advantages in select fracture cases, pending further validation.

Clinical bottom line

Biodegradable zinc-based implants represent a promising emerging option for fracture fixation in orthopedics, combining mechanical strength with gradual bioresorption. Early evidence suggests these implants may offer favorable biocompatibility and osteointegration compared to traditional metallic hardware, potentially reducing the need for secondary removal surgeries. However, clinical data remain limited and primarily preclinical or early-stage, warranting cautious interpretation. Orthopedic surgeons should consider zinc-based biodegradable implants as an investigational technology with potential advantages in select fracture cases, pending further validation.

What the evidence shows

Biodegradable implants have long been explored as alternatives to permanent metallic fixation devices to avoid complications such as stress shielding, implant-related infections, and the need for removal surgery (Leung et al., 1994). Zinc-based alloys have recently gained attention due to their intermediate degradation rates and favorable mechanical properties that better match cortical bone compared to magnesium or polymer-based materials (Review for "Bioglass and zinc incorporated PCL based composite as biodegradable implants for bone fixation", 2026).

Recent reviews of zinc-containing composites, such as bioglass and polycaprolactone (PCL) matrices, demonstrate promising in vitro and in vivo results. These materials support osteoblast proliferation and mineralization while gradually degrading without eliciting significant inflammatory responses (Review for "Bioglass and zinc incorporated PCL based composite as biodegradable implants for bone fixation", 2026). The controlled release of zinc ions may further promote bone regeneration and antimicrobial effects, potentially reducing infection risk.

Biomechanical studies comparing zinc-based implants to conventional titanium or stainless steel devices indicate comparable initial fixation strength and favorable load transfer characteristics, which are critical for fracture stability and healing (Review for "Comparing the performance of a femoral shaft fracture fixation using implants with biodegradable and non-biodegradable materials", 2024). The degradation profile of zinc alloys tends to be slower and more predictable than magnesium-based implants, potentially reducing rapid gas formation and implant loosening issues seen with some magnesium devices.

Despite these encouraging findings, clinical trials evaluating zinc-based biodegradable implants in human fracture fixation are scarce. Most data derive from animal models or composite material assessments, limiting direct extrapolation to routine clinical practice. The long-term effects of zinc ion release on systemic metabolism and local tissue response remain to be fully elucidated.

Caveats and uncertainty

Current evidence on zinc-based biodegradable implants is largely preclinical or early-phase, with a paucity of randomized controlled trials or large cohort studies in orthopedic patients. The heterogeneity in implant composition, manufacturing processes, and degradation environments complicates direct comparisons across studies (Review for "Bioglass and zinc incorporated PCL based composite as biodegradable implants for bone fixation", 2026).

Potential risks include unpredictable degradation rates in vivo influenced by patient factors such as local pH, vascularity, and comorbidities. Excessive zinc ion release could theoretically cause cytotoxicity or systemic effects, although this has not been conclusively demonstrated. The mechanical integrity of zinc alloys over the entire fracture healing period requires further validation to ensure sustained fixation without premature loss of stability.

Moreover, regulatory approvals and standardized manufacturing protocols for zinc-based implants are not yet established, limiting widespread clinical adoption. Cost-effectiveness analyses comparing these novel implants to existing fixation methods are also lacking.

How this may change practice

If ongoing research confirms safety, efficacy, and cost-effectiveness, biodegradable zinc-based implants could transform fracture fixation by eliminating the need for implant removal surgeries and reducing long-term complications associated with permanent hardware. Their osteoconductive and antimicrobial properties may improve healing outcomes, especially in challenging fractures or patients at high risk of infection.

Orthopedic surgeons should monitor emerging clinical trial data and consider involvement in investigational studies to gain experience with these implants. Early adoption may be appropriate in select cases where implant removal poses significant risks or in patients with contraindications to permanent metallic devices.

Multidisciplinary collaboration among surgeons, materials scientists, and regulatory bodies will be essential to optimize implant design, standardize protocols, and establish clinical guidelines for zinc-based biodegradable fixation devices.


References

  1. Leung Kwok-sui, et al. Biodegradable Implants in Fracture Fixation. Biodegradable Implants in Fracture Fixation. 1994 DOI:10.1142/9789814534208
  2. , et al. Review for "Bioglass and zinc incorporated PCL based composite as biodegradable implants for bone fixation". 2026 DOI:10.1088/2057-1976/ae7449/v1/review1
  3. , et al. Review for "Bioglass and zinc incorporated PCL based composite as biodegradable implants for bone fixation". 2026 DOI:10.1088/2057-1976/ae7449/v2/review1
  4. , et al. Review for "Comparing the performance of a femoral shaft fracture fixation using implants with biodegradable and non-biodegradable materials". 2024 DOI:10.1088/2057-1976/ad90e7/v2/review2

© 2026 Ablatotech, Inc. All rights reserved. Reviewed by the Ablatotech Vitals editorial team